CN Patent
CN114099691A — 一种人造细胞及其制备方法
Assigned to BOE Technology Group Co Ltd · Expires 2022-03-01 · 4y expired
What this patent protects
本申请公开了一种人造细胞及其制备方法,用以实现人造细胞的结构更接近真实细胞。本申请实施例提供的一种人造细胞,人造细胞包括:库伦汤凝聚物基质,以及包覆库伦汤凝聚物基质的磷脂囊泡。
USPTO Abstract
本申请公开了一种人造细胞及其制备方法,用以实现人造细胞的结构更接近真实细胞。本申请实施例提供的一种人造细胞,人造细胞包括:库伦汤凝聚物基质,以及包覆库伦汤凝聚物基质的磷脂囊泡。
Drugs covered by this patent
- Camptosar (Irinotecan Hydrochloride) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.